Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

Tennis, 1997, Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study, Neurology, 49, 542, 10.1212/WNL.49.2.542 Arif, 2007, Comparison and predictors of rash associated with 15 antiepileptic drugs, Neurology, 68, 1701, 10.1212/01.wnl.0000261917.83337.db Mockenhaupt, 2005, Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics, J Neurol, 64, 1134, 10.1212/01.WNL.0000156354.20227.F0 Hung, 2005, HLA-B genotyping to detect carbamazepine-induced Stevens–Johnson syndrome: implications for personalizing medicine, Personalized Med, 2, 225, 10.2217/17410541.2.3.225 Svensson, 2001, Cutaneous drug reactions, Pharmacol Rev, 53, 357 Chung, 2007, Human leukocyte antigens and drug hypersensitivity, Curr Opin Allergy Clin Immunol, 7, 317, 10.1097/ACI.0b013e3282370c5f Hung, 2006, Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions, Pharmacogenet Genom, 16, 297, 10.1097/01.fpc.0000199500.46842.4a Man, 2007, Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions, Epilepsia, 48, 1015, 10.1111/j.1528-1167.2007.01022.x Franciotta, 2009, Genetics basis for idiosyncratic reactions to antiepileptic drugs, Curr Opin Neurol, 22, 144, 10.1097/WCO.0b013e328328f276 Chen, 2009, Genetic structure of the Han Chinese population revealed by genome-wide SNP variation, Am J Hum Genet, 85, 775, 10.1016/j.ajhg.2009.10.016 Roujeau, 1994, The spectrum of Stevens–Johnson syndrome and toxic epidermal necrolysis: a clinical classification, J Invest Dermatol, 102, 28, 10.1111/1523-1747.ep12388434 Brodie, 1995, Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy, Lancet, 345, 476, 10.1016/S0140-6736(95)90581-2 Svensson, 2000, Cutaneous drug reactions, Pharmacol Rev, 53, 357 Chung, 2004, Medical genetics: a marker for Stevens–Johnson syndrome, Nature, 428, 486, 10.1038/428486a Locharernkul, 2008, Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population, Epilepsia, 49, 2087, 10.1111/j.1528-1167.2008.01719.x Kashiwagi, 2008, Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients, J Dermatol, 10, 683, 10.1111/j.1346-8138.2008.00548.x Ikeda, 2009, HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions, Epilepsia, 51, 297, 10.1111/j.1528-1167.2009.02269.x Alfirevic, 2006, HLA-B locus in Caucasian patients with carbamazepine hypersensitivity, Pharmacogenomics, 7, 813, 10.2217/14622416.7.6.813 Lonjou, 2006, for the RegiSCAR Group. A marker for Stevens–Johnson syndrome: ethnicity matters, Pharmacogenomics J, 6, 265, 10.1038/sj.tpj.6500356 Chung, 2010, Genetic predisposition of life-threatening antiepileptic-induced skin reactions, Expert Opin Drug Saf, 9, 15, 10.1517/14740330903427969 Toledano, 2008, Adverse effects of antiepileptic drugs, Semin Neurol, 28, 317, 10.1055/s-2008-1079336 Mackay, 1997, Safety of long-term lamotrigine in epilepsy, Epilepsia, 38, 881, 10.1111/j.1528-1157.1997.tb01252.x Hirsch, 2006, Predictors of lamotrigine-associated rash, Epilepsia, 47, 318, 10.1111/j.1528-1167.2006.00423.x Guberman, 1999, Lamotrigine associated rash: risk/benefit considerations in adults and children, Epilepsia, 40, 985, 10.1111/j.1528-1157.1999.tb00807.x Alvestad, 2007, Rash from antiepileptic drugs: influence by gender, age, and learning disability, Epilepsia, 48, 1360, 10.1111/j.1528-1167.2007.01109.x